Reduced muscle mass and bone size in pediatric patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 16, Issue 2, 2010, Pages 216-225

  Bechtold, Susanne ^a   Alberer, Martin ^a   Arenz, Tina ^a   Putzker, Stefanie ^a   Filipiak Pittroff, Birgit ^a   Schwarz, Hans Peter ^a   Koletzko, Sibylle ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bone density; Glucocorticoids; Inflammatory bowel disease; Muscle atrophy; Osteoporosis

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; INFLIXIMAB; MESALAZINE; SERUM ALBUMIN;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TRABECULAR BONE; ULCERATIVE COLITIS;

ADOLESCENT; BODY HEIGHT; BONE AND BONES; BONE DENSITY; CHILD; COLITIS, ULCERATIVE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MUSCLES; ORGAN SIZE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; YOUNG ADULT;

EID: 73949146915     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21021     Document Type: Article

References (40)

1. Mamula P, Markowitz JE, Baldasano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin N Am. 2003;32:967-995.
2. Gokhale R, Favus M, Karrison T, et al. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998;114:902-911.
3. Semeao EJ, Jawad AF, Stouffer NO, et al. Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr. 1999;135:593-600.
4. Sylvester FA, Wyzga N, Hyams JS, et al. Effect of Crohn's disease on bone metabolism in vitro: a role for Interleukin-6. J Bone Miner Res. 2002;17:695-702.
5. Semeao EJ, Stallings VA, Peck SN, et al. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology. 1997;112:1710-1713.
6. Thearle M, Horlick M, Bilezikian JP, et al. Osteoporosis: an unusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab. 2000;85:2122-2126.
7. Papaioannou A, Ferko NC, Adachi D. All patients with inflammatory bowel disease should have bone density assessment: pro. Inflamm Bowel Dis. 2001;7:158-162.
8. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42:188-194.
9. Gupta A, Paski S, Issenman R, et al. Lumbar spine mineral density at diagnosis and during follow-up in children with IBD. J Clin Densitom. 2004;7:290-295.
10. Kim SC, Ferry GD. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology. 2004;126:1550-1560.
11. Harpavat M, Greenspan SL, O'Brian C, et al. Altered bone mass at diagnosis of Crohn's disease: a pilot study. J Pediatr Gastroenterol Nutr. 2005;40:295-300.
12. Fewtrell MS. Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls. Arch Dis Child. 2003;88:95-798.
13. Ahmed SF, Horrocks IA, Patterson T, et al. Bone mineral assessment by dual energy x-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J Pediatr Gastroenterol Nutr. 2004;38:276-281.
14. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn's disease: independent effects of altered growth, maturation and body composition. J Bone Miner Res. 2004;19:1961-1968.
15. Schönau E, Neu CM, Beck B, et al. Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res. 2002;17:1095-1101.
16. Frost H. Defining osteopenia and osteoporosis: another view (with insight from a new paradigm). Bone. 1997;20:385-391.
17. IBD Working Group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1-7.
18. Hyams J, Markowitz JE, Ferry GD, et al. Development and validation of a paediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
19. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ. 1989;298:82-86.
20. Bunn S, Bisset WM, Main MJC, et al. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;32:171-177.
21. Brandt I, Reinken L. The growth rate of healthy children in the first 16 years: Bonn-Dortmund longitudinal developmental study. Klin Paediatr. 1988;200:451-456.
22. Neu C, Manz F, Rauch F, et al. Bone density and bone size at the distal radius in healthy children and adolescents: a study using peripheral quantitative computed tomography. Bone. 2001;28:227-232.
23. Neu C, Manz F, Rauch F, et al. Modeling of cross-sectional bone size and geometry at the proximal radius - a study of normal bone development using peripheral quantitative computed tomography. Osteoporos Int. 2001;12:538-547.
24. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Palo Alto, CA: Stanford University Press; 1959.
25. Tanner JM. Growth at adolescence. In: The development of the reproductive system, 2nd ed. Oxford: Blackwell; 1962. p 28-39.
26. Prader A, Largo RH, Wolf C. Timing of pubertal growth and maturation in the first Zurich longitudinal growth study. Acta Peadiatr Hung. 1984;25:155-159.
27. Rauch F, Neu CM, Wassmer G, et al. Muscle analysis by measurement of maximal isometric grip force: new reference data and clinical applications in pediatrics. Pediatr Res. 2002;51:505-510.
28. Pappa HM, Gordon CM, Saslowsky TM, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006;118:1950-1961.
29. Rauch F, Bailey DA, Baxter-Jones A, et al. The 'muscle-bone unit' during the pubertal growth spurt. Bone. 2004;34:771-775.
30. Ballinger AB, Camacho-Hubner C, Croft NM. Growth failure and intestinal inflammation. QJM. 2001;94:121-125.
31. Van Staa TP, Cooper C, Leufkens HGM, et al. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res. 2003;18:913-918.
32. Ballinger AB, Azooz O, El Haj T, et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut. 2000;46:694-700.
33. MacRae VE, Wong SC, Farquharson C, et al. Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases. Int J Mol Med. 2006;18:1011-1018.
34. Frost HM. Growth hormone and osteoporosis: an overview of endocrinological and pharmacological insights from the Utah paradigm of skeletal physiology. Horm Res. 2000;54(suppl 1):36-43.
35. Bartram S, Peaston RT, Rawlings DJ, et al. Multifaktoriell analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J Gastroenterol. 2006;12:5680-5686.
36. Cabré E, Gassull MA. Nutritional and metabolic issues in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2003;6:569-576.
37. Leonard MB. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics. 2007;119:116-174.
38. Lin CL, Moniz C, Chambers TJ, et al. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology. 1996;111:1263-1271.
39. Sentongo TA, Semeao EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn's disease. Am J Clin Nutr. 2002;76:1077-1081.
40. Burnham JM, Shults J, Petit MA, et al. Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn's disease or nephritic syndrome: impact of the underlying disease. J Bone Miner Res. 2007;22:551-559.